These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 62030)

  • 1. Intrathecal cytostatic therapy of meningeal carcinomatosis. Autoradiographic investigations of the CSF cells.
    Engelhardt P
    J Neurol; 1976 Oct; 213(4):309-15. PubMed ID: 62030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningeal carcinomatosis: treatment with intrathecal methotrexate.
    Bender RA
    Oncology; 1974; 30(4):328-33. PubMed ID: 4480422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
    Shapiro WR; Young DF; Mehta BM
    N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
    Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal cytostatic chemotherapy of meningitis carcinomatosa. Clinical manifestation and cerebrospinal fluid cytology in a case of metastatic carcinoma of the breast.
    Dommasch D; Przuntek H; Grüninger W; Mertens HG
    Eur Neurol; 1976; 14(3):178-91. PubMed ID: 179823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
    Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
    Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt].
    Miura M; Iijima N; Hayashida K; Kitazawa K; Ishii K; Ohara S
    Rinsho Shinkeigaku; 2006 Jun; 46(6):404-9. PubMed ID: 16986702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
    Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
    Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of meningeal carcinomatosis: diagnosis and treatment].
    Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T
    No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(Meningeal carcinomatosis in patients with breast cancer)].
    Freund M; Ostendorf P; Waller HD
    Onkologie; 1979 Dec; 2(6):243-8. PubMed ID: 398014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
    Wahidijat I; Markum AH; Abdulsalam M; Muslichan S; Odang O
    Acta Haematol; 1972; 47(2):81-8. PubMed ID: 4623363
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.
    Stemmler HJ; Schmitt M; Harbeck N; Willems A; Bernhard H; Lässig D; Schoenberg S; Heinemann V
    Oncol Rep; 2006 May; 15(5):1373-7. PubMed ID: 16596213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and Security of Intrathecal with Methotrexate in the Treatment of Meningeal Carcinomatosis].
    Wu X; Li J; Xiao J; Yang B; Yu L; Wu X; Wan J; Xu H; Kong J
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):252-6. PubMed ID: 27215452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients.
    Nakagawa H; Fujita T; Kubo S; Izumoto S; Nakajima Y; Tsuruzono K; Tokiyoshi K; Hayakawa T
    Surg Neurol; 1996 Mar; 45(3):256-64. PubMed ID: 8638223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrospinal fluid cytological diagnosis of primary and metastatic tumours of the central nervous system (author's transl)].
    Engelhardt P; Patzold U
    J Neurol; 1975; 209(1):45-57. PubMed ID: 50421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
    Kubo M; Jida M; Yamane M; Miyatani K; Udaka T; Sogabe O; Maeda H; Mizuta M; Shirakawa K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2097-9. PubMed ID: 16352935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer.
    Schabet M; Kloeter I; Adam T; Heidemann E; Wiethölter H
    Eur Neurol; 1986; 25(6):403-11. PubMed ID: 3792399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoplastic meningitis. Diagnosis and individualised therapy].
    Strik H; Prömmel P
    Nervenarzt; 2010 Feb; 81(2):229-41; quiz 242. PubMed ID: 20140544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of meningeal carcinomatosis showing myelopathy--detection of TNF-alpha in infiltrating CSF cells and brain tissue sections of cerebellum].
    Nakamura S; Kogure K
    Rinsho Shinkeigaku; 1993 Feb; 33(2):182-6. PubMed ID: 8319390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.